These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 34695521

  • 1. A systematic review of intraluminal high dose rate brachytherapy in the management of malignant biliary tract obstruction and cholangiocarcinoma.
    Taggar AS, Mann P, Folkert MR, Aliakbari S, Myrehaug SD, Dawson LA.
    Radiother Oncol; 2021 Dec; 165():60-74. PubMed ID: 34695521
    [Abstract] [Full Text] [Related]

  • 2. Clinical benefit of radiation therapy and metallic stenting for unresectable hilar cholangiocarcinoma.
    Isayama H, Tsujino T, Nakai Y, Sasaki T, Nakagawa K, Yamashita H, Aoki T, Koike K.
    World J Gastroenterol; 2012 May 21; 18(19):2364-70. PubMed ID: 22654427
    [Abstract] [Full Text] [Related]

  • 3. Intraluminal brachytherapy with metallic stenting in the palliative treatment of malignant obstruction of the bile duct.
    Kocak Z, Ozkan H, Adli M, Garipagaoglu M, Kurtman C, Cakmak A.
    Radiat Med; 2005 May 21; 23(3):200-7. PubMed ID: 15940068
    [Abstract] [Full Text] [Related]

  • 4. Intraluminal Brachytherapy in Unresectable Extrahepatic Biliary Duct Cancer: An Italian Pooled Analysis.
    Autorino R, Bisiello S, Pappalardi B, Privitera V, Buwenge M, Piccolo F, Masciocchi C, Tagliaferri L, Macchia G, Curti CD, Luppatteli M, Cerrotta A, Morganti AG, Valentini V, Mattiucci G.
    Anticancer Res; 2020 Jun 21; 40(6):3417-3421. PubMed ID: 32487639
    [Abstract] [Full Text] [Related]

  • 5. Combination of external beam irradiation and high-dose-rate intraluminal brachytherapy for inoperable carcinoma of the extrahepatic bile ducts.
    Shin HS, Seong J, Kim WC, Lee HS, Moon SR, Lee IJ, Lee KK, Park KR, Suh CO, Kim GE.
    Int J Radiat Oncol Biol Phys; 2003 Sep 01; 57(1):105-12. PubMed ID: 12909222
    [Abstract] [Full Text] [Related]

  • 6. A Systematic Review and Meta-analysis of Intraluminal Brachytherapy Versus Stent Alone in the Treatment of Malignant Obstructive Jaundice.
    Xu X, Li J, Wu J, Zhu R, Ji W.
    Cardiovasc Intervent Radiol; 2018 Feb 01; 41(2):206-217. PubMed ID: 29075881
    [Abstract] [Full Text] [Related]

  • 7. Comparing the Safety and Efficacy of Intraluminal Brachytherapy vs Isolated Percutaneous Transhepatic Biliary Drainage with internalization for Unresectable Malignant Biliary Obstruction: A Prospective Observational Study.
    Sood S, Alexander JV, Gupta M, Chauhan A.
    Hematol Oncol Stem Cell Ther; 2023 Jul 20; 17(1):21-28. PubMed ID: 37581465
    [Abstract] [Full Text] [Related]

  • 8. Intraluminal brachytherapy in the treatment of pancreas and bile duct carcinoma.
    Montemaggi P, Costamagna G, Dobelbower RR, Cellini N, Morganti AG, Mutignani M, Perri V, Brizi G, Marano P.
    Int J Radiat Oncol Biol Phys; 1995 May 15; 32(2):437-43. PubMed ID: 7538501
    [Abstract] [Full Text] [Related]

  • 9. Malignant biliary duct obstruction: long-term experience with Gianturco stents and combined-modality radiation therapy.
    Eschelman DJ, Shapiro MJ, Bonn J, Sullivan KL, Alden ME, Hovsepian DM, Gardiner GA.
    Radiology; 1996 Sep 15; 200(3):717-24. PubMed ID: 8756921
    [Abstract] [Full Text] [Related]

  • 10. Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report.
    Macchia G, Costamagna G, Morganti AG, Mutignani M, Giuliante F, Clemente G, Deodato F, Smaniotto D, Mattiucci GC, Sallustio G, Valentini V, Nuzzo G, Cellini N.
    Dig Liver Dis; 2005 Aug 15; 37(8):615-8. PubMed ID: 15890567
    [Abstract] [Full Text] [Related]

  • 11. Endoscopic intraluminal brachytherapy and metal stent in malignant hilar biliary obstruction: a pilot study.
    Singh V, Kapoor R, Solanki KK, Singh G, Verma GR, Sharma SC.
    Liver Int; 2007 Apr 15; 27(3):347-52. PubMed ID: 17355456
    [Abstract] [Full Text] [Related]

  • 12. A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer.
    Mattiucci GC, Autorino R, Tringali A, Perri V, Balducci M, Deodato F, Gambacorta MA, Mantini G, Tagliaferri L, Mutignani M, Morganti AG.
    Brachytherapy; 2015 Apr 15; 14(3):401-4. PubMed ID: 25591935
    [Abstract] [Full Text] [Related]

  • 13. Long-term survival after intraluminal brachytherapy for inoperable hilar cholangiocarcinoma: a case report.
    Chan SY, Poon RT, Ng KK, Liu CL, Chan RT, Fan ST.
    World J Gastroenterol; 2005 May 28; 11(20):3161-4. PubMed ID: 15918211
    [Abstract] [Full Text] [Related]

  • 14. Intraluminal brachytherapy in bile duct carcinomas.
    Leung J, Guiney M, Das R.
    Aust N Z J Surg; 1996 Feb 28; 66(2):74-7. PubMed ID: 8602818
    [Abstract] [Full Text] [Related]

  • 15. Impact of intraluminal brachytherapy on survival outcome for radiation therapy for unresectable biliary tract cancer: a propensity-score matched-pair analysis.
    Yoshioka Y, Ogawa K, Oikawa H, Onishi H, Kanesaka N, Tamamoto T, Kosugi T, Hatano K, Kobayashi M, Ito Y, Takayama M, Takemoto M, Karasawa K, Nagakura H, Imai M, Kosaka Y, Yamazaki H, Isohashi F, Nemoto K, Nishimura Y, Japanese Radiation Oncology Study Group (JROSG).
    Int J Radiat Oncol Biol Phys; 2014 Jul 15; 89(4):822-9. PubMed ID: 24969796
    [Abstract] [Full Text] [Related]

  • 16. Brachytherapy and percutaneous stenting in the treatment of cholangiocarcinoma: a prospective randomised study.
    Válek V, Kysela P, Kala Z, Kiss I, Tomásek J, Petera J.
    Eur J Radiol; 2007 May 15; 62(2):175-9. PubMed ID: 17344008
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of high-dose-rate intraluminal brachytherapy by percutaneous transhepatic biliary drainage in the palliative management of malignant biliary obstruction--a pilot study.
    Aggarwal R, Patel FD, Kapoor R, Kang M, Kumar P, Chander Sharma S.
    Brachytherapy; 2013 May 15; 12(2):162-70. PubMed ID: 23186613
    [Abstract] [Full Text] [Related]

  • 18. HDR-192Ir intraluminal brachytherapy in treatment of malignant obstructive jaundice.
    Chen Y, Wang XL, Yan ZP, Cheng JM, Wang JH, Gong GQ, Qian S, Luo JJ, Liu QX.
    World J Gastroenterol; 2004 Dec 01; 10(23):3506-10. PubMed ID: 15526374
    [Abstract] [Full Text] [Related]

  • 19. Role of intraluminal brachytherapy in extrahepatic bile duct and pancreatic cancers: is it just for palliation?
    Montemaggi P, Morganti AG, Dobelbower RR, Brizi G, Smaniotto D, Costamagna G, Cellini N, Marano P.
    Radiology; 1996 Jun 01; 199(3):861-6. PubMed ID: 8638018
    [Abstract] [Full Text] [Related]

  • 20. Intraluminal brachytherapy in the treatment of bile duct carcinomas.
    Leung JT, Kuan R.
    Australas Radiol; 1997 May 01; 41(2):151-4. PubMed ID: 9153812
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.